Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,320,469
in 18 filings, $12.5M under 10b5-1 plans

Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-10 Kaye Edward M. MD Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 HENDERSON JOHN T Director Grant or award +5,000 30,420
2023-05-10 HENDERSON JOHN T Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 Harrington Robert Arthur Director Grant or award +5,000 10,551
2023-05-10 Harrington Robert Arthur Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 COSTA SANTO J Director Grant or award +5,000 15,000
2023-05-10 COSTA SANTO J Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-10 Bhanji Muna Director Grant or award +5,000 16,031
2023-05-10 Bhanji Muna Director Grant or award · Non-Qualified Stock Option (Right to Buy) +10,000 10,000
2023-05-03 Malik Fady Ibraham EVP Research & Development Exercise or conversion 10b5-1 +7,000 $7.96 $56K 174,183
2023-05-03 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −7,000 $40.00 $280K 167,183
2023-05-03 Malik Fady Ibraham EVP Research & Development Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −7,000 74,322
2023-04-28 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $9.65 $121K 453,558
2023-04-28 Blum Robert I President & CEO Sale 10b5-1 −12,500 $37.68 $471K 441,058
2023-04-28 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 83,191
2023-04-14 Blum Robert I President & CEO Exercise or conversion 10b5-1 +12,500 $9.65 $121K 453,558
2023-04-14 Blum Robert I President & CEO Sale 10b5-1 −12,500 $35.61 $445K 441,058
2023-04-14 Blum Robert I President & CEO Exercise or conversion · Non-Qualified Stock Option (Right to Buy) 10b5-1 −12,500 95,691
2023-04-13 Malik Fady Ibraham EVP Research & Development Sale 10b5-1 −4,000 $34.21 $137K 167,183
2023-04-03 Harrington Robert Arthur Director Grant or award +298 $37.71 $11K 5,551

Page 42 of 45 · 885 trades